QQ客服 官方微博 反馈留言

	Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis
	Feng, Fubin; Yin, Fang; Zhang, Tingting; Liu, Cun; Sun, Changgang
刊名	EXPERT OPINION ON DRUG SAFETY
	2018
卷号	17期号:12页码:1151-1152
DOI	10.1080/17446651.2018.1545367
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4576928
专题	山东大学
作者单位	1.Weifang Tradit Chinese Hosp, Dept Oncol, 1055 Weizhou Rd, Weifang, Shandong, Peoples R China. 2.Weifang Peo
推荐引用方式 GB/T 7714	Feng, Fubin,Yin, Fang,Zhang, Tingting,et al. Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis[J]. EXPERT OPINION ON DRUG SAFETY,2018,17(12):1151-1152.
APA	Feng, Fubin,Yin, Fang,Zhang, Tingting,Liu, Cun,&Sun, Changgang.(2018).Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis.EXPERT OPINION ON DRUG SAFETY,17(12),1151-1152.
MLA	Feng, Fubin,et al."Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis".EXPERT OPINION ON DRUG SAFETY 17.12(2018):1151-1152.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。